Skip to content
Search

Latest Stories

Pharmacist Support to expand its support to ensure mental wellbeing of pharmacy professionals

Pharmacist Support charity has announced new plans to further expand its wellbeing support to ensure better mental health in pharmacy.

The announcement from the charity has come at a time when pharmacy teams have been facing immense work pressure due to rising Covid-19 cases, a nationwide third lockdown and mass vaccination drive to fight the pandemic.


Using feedback received from its recent wellbeing-focused campaign and research, Pharmacist Support aims to address some of the gaps in the support being provided as well as the issues raised around awareness, confidentiality and stigma around mental health in pharmacy.

Danielle Hunt, chief executive at Pharmacist Support, said: “Our recent research has given us a clear steer on what is needed and this has helped us shape our new five year strategy and plans for the coming year.

“There are some evident gaps in support and barriers to access that we hope to address. Over the next twelve months the charity will look to develop a clear pathway of support that includes more practical and emotional support. We also plan to enhance our volunteer schemes to ensure they reflect the diverse experiences, backgrounds and needs of the individuals within it, as well as to help us increase awareness.”

Danielle further added: “Following the success of this year’s wellbeing campaign, we are also committed to running our ACTNow campaign again in 2021 and are delighted to announce the continued involvement and support of the Pharmacists’ Defence Association (PDA).

“Without the continued support of our partners and sponsors, and in particular the PDA, vital support and activities such as our ACTNow campaign would not be possible. Their regular donations year on year give us security and allow us to plan ahead and make long term improvements to the services we provide to thousands of pharmacists and students who seek our assistance every year.”

Another strand of the charity’s work in 2021, again highlighted through the survey results, will be around workplace culture. “Working in partnership with others in the sector, the charity hopes to support a shift in attitude and has committed to work with other organisations to encourage and help progress the destigmatisation of mental health in pharmacy,” the charity has said.

Through its ACTNow campaign, and in particular the popular ‘Your Stories’ features, the charity has initiated open conversations in the sector around mental health and wellbeing.

It is their hope to continue this conversation more broadly through the introduction of new events, online workshops and through its volunteer schemes.

More For You

Scottish community pharmacist working in high street pharmacy with supportive environment

The PDA wants investment to reach those who deliver services to patients every day

Pic credit: iStock

Funding boost in Scotland “needs to work for not just pharmacy owners but pharmacists too”, says PDA

An increase in funding for community pharmacies in Scotland needs to lead to a greater focus on supporting pharmacists rather than “simply sustain business models”, according to the Pharmacy Defence Association (PDA).

Earlier this week, Community Pharmacy Scotland (CPS) accepted the Scottish government’s initial financial offer for the 2025/26 fiscal year, securing a guaranteed minimum reimbursement of £120 million for community pharmacies — up from £110 million from 2024/25.

Keep ReadingShow less
Aspire Pharma acquisition boosts access to essential medicines for NHS patients in the UK

The acquisition is expected to further drive the company’s growth.

gettyimages

Aspire acquires UK distribution rights from Tetris

Aspire Pharma Limited, one of the UK’s fastest-growing specialty niche generics companies, has announced the acquisition of UK distribution rights to a number of products from Tetris Pharma, a subsidiary of Arecor Therapeutics.

These include products used in the treatment of bacterial infections—such as injectable and intravenous antibiotics—as well as a medicine indicated for acute myocardial infarction (MI) and deep vein thrombosis (DVT).

Keep ReadingShow less
GP surgery upgrades for annual appointments

The surgeries will have additional space to “see more patients, boost productivity and improve patient care”

Pic credit: iStock

GP surgery upgrades to create 8.3 million more annual appointments

Over 1,000 GP surgeries will have their premises modernised to meet the needs of a further 8.3 million appointments each year, the government has announced.

Backed by a cash injection of over £102 million, the surgeries will have additional space to “see more patients, boost productivity and improve patient care”.

Keep ReadingShow less
Wales boosts funding for pharmacy-led UTI and sore throat test services

The sore throat test (STTT) and treat service will be widely available

Pic credit: istock

Welsh pharmacies receive funding boost for clinical services

Two key clinical services will be available in 99 per cent of community pharmacies across Wales after a boost in funding.

The sore throat test (STTT) and treat service and the urinary tract infection (UTI) service have both benefitted from contractual negotiations between the Welsh Government and Community Pharmacy Wales (CPW).

Keep ReadingShow less
Paul Bennett
Paul Bennett, CEO, Royal Pharmaceutical Society
Paul Bennett, CEO, Royal Pharmaceutical Society

Pharmacists need to take advantage of independent prescribing pathways, says Bennett

Independent prescribing will be a “significant point” in the history of community pharmacy, according to Royal Pharmaceutical Society chief executive Paul Bennett.

Last month, the RPS announced the launch of a comprehensive new prescribing development programme to support pharmacists across all stages of their prescribing careers.

Keep ReadingShow less